Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstrm SZ, Davies MJ, et al
+ 1 sources In addition the results of its expert testing, ConsumerLab uses only high-quality, evidence based, information sources
The GOAL-HF1 trial, investigating the safety and efficacy of ghrelin in patients with HFrEF, is currently ongoing and represents an important step toward determining the therapeutic potential of ghrelin in HF
GLP-1 medications for diabetes and weight loss have proven to be highly effective
1998;1:136-141 Leyden J, Stephens T, Finkey MB, Appa, Y, Barkovic S, Skin Care Benefits of Copper Peptide Containing Facial Cream
Increases in heart rate were seen among patients who were treated with GLP-1RAs in both those taking -blockers at baseline and -blocker-nave patients, whereas the heart rate remained stable in those receiving non-GLP-1RA treatments in both -blocker subgroups